VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.

535-0820-00L 1 Credits

Therapeutic proteins

Therapeutische Proteine

Lecturers & Examiners: Prof. Dr. Dario Neri
VVZ CR n/a

Last Updated: 2026-02-05 14:59:36

Abstract

Get students familiar with advanced Immunological concepts of Pharmaceutical Relevance, with a special focus on the development of therapeutic strategies based on the administration of therapeutic proteins to patients.Discuss features of the main recombinant biopharmaceuticals approved in Europe and in the U.S.

Objective

Get students familiar with advanced Immunological concepts of Pharmaceutical Relevance, with a special focus on the development of therapeutic strategies based on the administration of therapeutic proteins to patients. Discuss features of the main recombinant biopharmaceuticals approved in Europe and in the U.S.

Content

0. Chapters 11-14 of the Janaway et al. "Immunobiology V" book (Garland) 1. A brief history of biotech industry 2. Recombinant cytokines and growth hormones 3. Recombinant blood coagulation and growth hormones 4. Recominant vaccines 5. Recombinant antibodies 6. Miscallaneaous 7. IPR considerations 8. Future perspectives

Resources

Literature

Immunobiology: The Immune System in Health & Disease Sixth Edition Charles A. Janeway, Paul Travers, Mark Walport, Mark Shlomchik © 2004 Paperback [ www.garlandscience.com ] AND Gary Walsh (2003) "Biopharmaceutical benchmark - 2003", Nature Biotechnology, vol. 21, pages 865-870. (including tables)

General Information

Language
German
Frequency
Yearly recurring

Examination

Type
session examination
Mode
oral 30 minutes

Course Components

Type Title Time & Place Hours
lecture Therapeutische Proteine
gemäss separatem Programm
  • Tue 08:00-09:35 (HIL E 9)
1 h weekly

Offered In